Kadcyla
| Kadcyla | |
|---|---|
| Term | Kadcyla |
| Short definition | Kadcyla (kad-SY-luh) A drug used to treat certain patients with HER2-positive breast cancer who have already been treated with trastuzumab and a certain cancer drug called taxane. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Kadcyla - (pronounced) (kad-SY-luh) A drug used to treat certain patients with HER2-positive breast cancer who have already been treated with trastuzumab and a certain cancer drug called taxane. It is also being studied in the treatment of other types of cancer. Kadcyla contains a monoclonal antibody called trastuzumab that attaches to a protein called HER2, which is found on some breast cancer cells. It also contains a cancer drug called DM1, which can help kill cancer cells. Kadcyla is a type of antibody-drug conjugate. Also called ado-trastuzumab emtansine and T-DM1
External links
- Medical encyclopedia article on Kadcyla
- Wikipedia's article - Kadcyla
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski